PubRank

J McMichael

Author PubWeight™ 67.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The portal circulation: I. The action of adrenaline and pituitary pressor extract. J Physiol 1932 6.88
2 CARDIAC CATHETERIZATION IN CASES OF PATENT INTERAURICULAR SEPTUM, PRIMARY PULMONARY HYPERTENSION, FALLOT'S TETRALOGY, AND PULMONARY STENOSIS. Br Heart J 1947 2.57
3 The portal circulation: II. The action of acetylcholine. J Physiol 1933 2.49
4 Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg 1998 2.31
5 Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 1995 1.96
6 Reorientations in Hypertensive Disorders-II. Br Med J 1961 1.82
7 Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995 1.59
8 Weaning of immunosuppression in liver transplant recipients. Transplantation 1997 1.57
9 Practical Management of Wound Shock. Br Med J 1942 1.50
10 Foreword. Br J Ophthalmol 1966 1.36
11 History of atrial fibrillation 1628-1819 Harvey - de Senac - Laënnec. Br Heart J 1982 1.34
12 Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995 1.31
13 Hepatic Retransplantation--an analysis of risk factors associated with outcome. Transplantation 1996 1.22
14 Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted? Transplantation 1994 1.18
15 A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. Transplantation 1998 1.16
16 Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. Am J Gastroenterol 1995 1.16
17 Reorientations in Hypertensive Disorders. Br Med J 1961 1.13
18 Sir James Mackenzie and atrial fibrillation--a new perspective. J R Coll Gen Pract 1981 1.10
19 Fats and atheroma: an inquest. Br Med J 1979 1.06
20 Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. Am J Gastroenterol 1995 1.05
21 Predicting outcomes after liver transplantation. A connectionist approach. Ann Surg 1994 1.02
22 Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics. Curr Pharm Des 2004 0.97
23 Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. Ann Surg 1996 0.95
24 Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Transplantation 1997 0.95
25 Letter: Diet and exercise in coronary heart-disease. Lancet 1974 0.95
26 THE PATHOLOGY OF ARSENO-THERAPY JAUNDICE. Br J Vener Dis 1943 0.93
27 Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc 1998 0.91
28 HLA and cross-reactive antigen group matching for cadaver kidney allocation. Transplantation 1997 0.89
29 Letter: Prevention of coronary heart-disease. Lancet 1976 0.88
30 Diet and coronary heart disease. Br Med J 1977 0.87
31 Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transpl Surg 1998 0.86
32 Extensive Visceral Endarteritis Obliterans in a Young Child. Arch Dis Child 1929 0.85
33 Experimental parainfluenza type 1 virus-induced encephalomyelopathy in adult mouse: a histopathological study. Acta Neuropathol 1975 0.84
34 A randomised prospective comparison of cefotaxime versus netilmicin/penicillin for treatment of suspected neonatal sepsis. Drugs 1988 0.83
35 Renal transplantation under FK 506 in African-Americans: early experience. Transplant Proc 1993 0.83
36 The Postgraduate Medical School: the present situation. Postgrad Med J 1966 0.82
37 Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy. Transplant Proc 1991 0.81
38 Tacrolimus for rescue of refractory renal allograft rejection. Transplant Proc 1998 0.81
39 French wine and death certificates. Lancet 1979 0.81
40 Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. Transplant Proc 1998 0.80
41 Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. Transplant Proc 1997 0.79
42 Stimulated response of peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients receiving a cyclosporine+rapamycin regimen. Transplantation 2000 0.79
43 Role of pharmacokinetic-pharmacodynamic principles in rational and cost-effective drug development. Ther Drug Monit 1996 0.79
44 Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. Transplant Proc 1997 0.79
45 Hepatic and intestinal transplantation at the University of Pittsburgh. Clin Transpl 1998 0.78
46 Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up. Transplant Proc 1999 0.78
47 A clinical sciences institute. Med J Aust 1965 0.77
48 Vascular Disease: An Indirect Approach. Can Med Assoc J 1961 0.77
49 Digitalis in the last half century. Eur Heart J 1982 0.77
50 Dietetic factors in coronary disease. Eur J Cardiol 1977 0.76
51 Kidney transplantation with bone marrow augmentation: five-year outcomes. Transplant Proc 2001 0.76
52 Building clinical classifiers using incomplete observations--a neural network ensemble for hepatoma detection in patients with cirrhosis. Methods Inf Med 1995 0.76
53 Observations out of time. Ulster Med J 1965 0.76
54 Performance of multi-layer feedforward neural networks to predict liver transplantation outcome. Methods Inf Med 1996 0.76
55 The current status of hepatic transplantation at the University of Pittsburgh. Clin Transpl 1995 0.76
56 Five-year experience with tacrolimus rescue for renal allograft rejection. Transplant Proc 1997 0.75
57 Posttransplant hypertension in blacks versus nonblacks. Transplant Proc 1993 0.75
58 Xenotransplantation of hematopoietic cells resistant to HIV as a potential treatment for patients with AIDS. Transplant Proc 1994 0.75
59 Effect of recipient race on waiting time for renal transplantation at the University of Pittsburgh. Transplant Proc 1993 0.75
60 Future of postgraduate medical education. Lancet 1969 0.75
61 The university in medicine and cardiology. Br Heart J 1971 0.75
62 Organisation of the Medical Services in the U.S.S.R. Postgrad Med J 1942 0.75
63 Erucic acid and the Spanish oil epidemic. Lancet 1981 0.75
64 Academic cardiology at Hammersmith Hospital. Lancet 1992 0.75
65 Chance and the unexpected. Scott Med J 1977 0.75
66 Coronary artery disease opening remarks. Adv Cardiol 1970 0.75
67 Annual oration on clinical science and clinical sense. Trans Med Soc Lond 1968 0.75
68 Prevention of coronary heart-disease. Lancet 1976 0.75
69 British postgraduate medical Federation. J R Soc Med 1978 0.75
70 In vitro effects and clinical evaluation of a human chorionic gonadotrophin preparation in acute leukemia. Leukemia 1998 0.75
71 Consultant posts in cardiology. Lancet 1969 0.75
72 Financing research. Proc R Soc Med 1968 0.75
73 The evaluation of drugs. J Ir Med Assoc 1968 0.75
74 Changing patterns in higher education. Proc R Soc Med 1977 0.75
75 Max Leonard Rosenheim, 1908-1972. Trans Assoc Am Physicians 1973 0.75
76 Why blame cholesterol? Lancet 1979 0.75
77 Professor Dame Sheila Sherlock. Gut 1978 0.75
78 Research and understanding. Postgrad Med J 1973 0.75
79 The revolution in cardiac diagnosis. Clin Radiol 1970 0.75
80 Fats and arterial disease. Am Heart J 1979 0.75
81 Diet and coronary disease. Acta Med Scand 1980 0.75